key: cord-0906024-g33nx774 authors: Reed, Isaiah G.; Walker, Ethan S.; Landguth, Erin L. title: SARS-CoV-2 Serial Interval Variation, Montana, USA, March 1–July 31, 2020 date: 2021-05-03 journal: Emerg Infect Dis DOI: 10.3201/eid2705.204663 sha: 6a6ed45ff969c4b607bb79bc72836b48dcb35839 doc_id: 906024 cord_uid: g33nx774 We report mean severe acute respiratory syndrome coronavirus 2 serial intervals for Montana, USA, from 583 transmission pairs; infectors’ symptom onset dates occurred during March 1–July 31, 2020. Our estimate was 5.68 (95% CI 5.27–6.08) days, SD 4.77 (95% CI 4.33–5.19) days. Subperiod estimates varied temporally by nonpharmaceutical intervention type and fluctuating incidence. We report mean severe acute respiratory syndrome coronavirus 2 serial intervals for Montana, USA, from 583 transmission pairs; infectors' symptom onset dates occurred during March 1-July 31, 2020. Our estimate was 5.68 (95% CI 5.27-6.08) days, ) days. Subperiod estimates varied temporally by nonpharmaceutical intervention type and fl uctuating incidence. We analyzed data using R version 3.6.2 and the EpiEstim package (3, 4) . Complying with EpiEstim functional requirements, we assigned pairs with a zero-valued SI an upper bound of 1 day, with lower bounds unchanged (n = 52 pairs). No negative-valued SIs were identified. We excluded pairs with a SI >2 incubation periods (>28 days). We determined that a gamma distribution was most appropriate using the R0 package est.GT function (5) . Next, we used EpiEstim estimate_R, with case-pair and daily incidence data, to perform a Bayesian estimation of the SI gamma distribution using Markov chain Monte Carlo specified for the joint posterior sample of possible SI values (6, 7) . Montana's overall mean SI estimate was 5.68 (95% CI 5.27-6.08) days ] days) ( Figure 2 ). Pre-SIP provided the longest subperiod estimate, days. The SI shortened during SIP, to ) days, and again during phase 1, to days. However, the SI lengthened during phase 2 (June) to 6.23 (95% CI 5.59-6.85) days, almost reaching pre-SIP levels. Phase 2 (July) demonstrated a sharp reduction to the shortest SI observed, days. Sensitivity analyses of NPI impact delays resulted in altered subperiod estimates, especially for phase 1 relative to other subperiods (Table 2) . Additional sensitivity analyses, comparing forward-and backward-looking SIs, produced vastly dissimilar point estimates and trends. Analysis of SARS-CoV-2 transmission in Montana during March 1-July 31, 2020, identified a mean SI of 5.68 (95% CI 5.27-6.08) days, falling within the bounds of 16 of 24 published estimates from more urbanized settings across the globe (Table 1; Figure 1 ). However, an aggregate estimate derived from data spanning multiple outbreak stages may not accurately describe Montana-based transmission because changing contact patterns and environmental influences may cause variation (1, 2) . Temporal analyses suggest that NPIs influenced transmission patterns, as demonstrated by Montana's epidemic curve and fluctuating SI values ( Figure 2 ). Ali found that SIs shorten as stricter NPIs are applied (1, 8) , which our subperiod estimates mostly support. However, phase 2 (July) contradicts the premise, with the shortest subperiod SI and a less restrictive NPI (Table 2) . Furthermore, when accounting for NPI impact delays, the alignment falters during phase 2. This difference may occur because Ali did not assess additional epidemic waves, which complicates direct NPI comparisons (1). Park agreed with Ali, while also offering a mathematical proof for the relationship between epidemic growth rates, calculated from incidence data, and forward-looking SIs (2, 9) . Park showed that as growth rates increase, forward SIs lengthen, and that when incidence decreases (either over time or because of external factors) forward SIs shorten (2) . This better describes Montana's incidence and our subperiod estimates, with NPIs providing context ( Figure 2 ). Increased incidence and longer SIs during pre-SIP and phase 2 (June) stem from nonexistent and relaxed NPIs, whereas decreased incidence and shorter SIs during SIP and phase 2 (July) likely result from stricter NPIs and increased compliance with public health recommendations (e.g., mask wearing and social distancing). Additional data describing social compliance would benefit this interpretation. The first limitation of this study is that the proportion of cases with identifiable transmission chains was lower during July than in previous periods. Despite this limitation, we felt it was necessary to report an SI for a period experiencing sizable incidence fluctuations. In addition, whereas others have reported negative-valued SIs among 1.2%-14.46% of infector-infectee pairs (10) (11) (12) (13) (14) , we failed to identify any within our data. This difference could be caused by multiple factors, including incorrectly reported symptom onset dates, misidentified transmission direction between pairs, or both. However, the absence of negative SIs was not unique to our study; 14 of 24 published SI estimates did not include negative-valued pairs (Table 1) . Furthermore, to include pairs with a zerovalued SI, our study required changing their upper range. A sensitivity analysis of the adjustment showed minimal impact to the resulting estimate, whereas another sensitivity analysis, examining zero-valued pairs' exclusion, returned a substantially elevated estimate. These analyses indicate that nontraditional SIs play key roles in generation time, SI, and R 0 studies, especially for SARS-CoV-2, and that inclusive methods should be used when possible. Our study offers evidence that rural-based SARS-CoV-2 SI estimates are consistent with those describing transmission occurring in urban settings. Furthermore, temporal variations in incidence, which can be caused by NPIs, must be considered when assessing SI distributions and other transmission measures. More period-based analyses of varying NPIs and their effects on transmission dynamics would help corroborate these findings. Table 2 . B) SI estimates and 95% CIs (error bars). Overall mean SI was 5.68 (95% CI 5.27-6.08) days, overall ) days. For subperiod SI and SD estimates, see the Forward section of Table 2 he manages the state's hospital discharge data and public health data visualization systems. His primary research interests include infectious disease modeling, vectorborne disease, and global health. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions Forward-looking serial intervals correctly link epidemic growth to reproduction numbers R: A language and environment for statistical computing EpiEstim: estimate time varying reproduction numbers from epidemic curves R 0 : estimation of R 0 and real-time reproduction number from epidemics. R package version 1.2-6 Estimating incubation period distributions with coarse data Improved inference of time-varying reproduction numbers during infectious disease outbreaks Rapid review of available evidence on the serial interval and generation time of COVID-19 Estimating initial epidemic growth rates Serial interval of COVID-19 among publicly reported confirmed cases Temporal dynamics in viral shedding and transmissibility of COVID-19 Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea Serial interval distribution of SARS-CoV-2 infection in Brazil Estimating transmission dynamics and serial interval of the first wave of COVID-19 infections under different control measures: a statistical analysis in Tunisia from Address for correspondence: Isaiah G. Reed, Montana Department of Public Health and Human Services Despite Predeparture Testing • Evaluation of National Event-Based Surveillance • Clinical Features and Comparison of Kingella and Non-Kingella Endocarditis in Children, Israel • Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis • Testing during COVID-19 Pandemic Decentralized Care for Rifampicin-Resistant Tuberculosis, Western Cape, South Africa • Transmission of Antimicrobial-Resistant Staphylococcus aureus Clonal Complex 9 between Pigs and Humans, United States • Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland • Clusters of Drug • Daily Forecasting of Regional Epidemics of Coronavirus Disease with Bayesian Uncertainty • Quantification, United States Fluconazole-Resistant Candida glabrata Bloodstream Isolates • Excess All-Cause Deaths during Coronavirus Disease Pandemic • Mycoplasma genitalium and Other Reproductive Tract Infections in Pregnant Women • Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis • Familial Clusters of Coronavirus Disease in 10 Prefectures • Population-Based Geospatial and Molecular Epidemiologic Study of Tuberculosis Transmission Dynamics Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients Genomic Characterization of hlyF-positive Shiga Toxin-Producing Escherichia coli • Isolate-Based Surveillance of Bordetella pertussis Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys • Foodborne Origin and Local and Global Spread of Staphylococcus saprophyticus Causing Human Urinary Tract Infections • Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel • Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection • Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and We thank Montana's local county and tribal health jurisdictions for their dedication and commitment in responding to the COVID-19 pandemic and for collecting the data used in this study. We also thank the Montana Department of Public Health and Human Services, Communicable Disease Epidemiology Section, for allowing us access to the state's COVID-19 case investigation data; the authors of the serial interval publications referenced in this paper who kindly responded to our inquiries concerning their studies; as well as Todd Harwell, Curtis Noonan, Erin Semmens, Jeffrey Shaman, Scott Whittenburg, Laura Williamson, and the anonymous reviewers for offering feedback on the manuscript.